Back
ProShares Ultra Gold Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
47
UGL
ProShares Ultra Gold
Last Price:
$115.89
Seasonality Move:
0.39%
Sell
46
SRPT
Sarepta Therapeutics
Last Price:
$49.61
Seasonality Move:
15.14%
Sell
47
ProShares Ultra Gold (UGL)
is a Sell
Is ProShares Ultra Gold a Buy, Sell or Hold?
-
The current ProShares Ultra Gold [UGL] share price is $115.42. The Score for UGL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
UGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $52.40. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UGL Stock Price Chart
What is ProShares Ultra Gold's stock price today?
-
The ProShares Ultra Gold share price today is $115.42The current trend is moderately bearish and UGL is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $52.40Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
UGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.67 | Buy |
| Relative Strength Index (14 RSI): | 42.91 | Sell |
| Chaikin Money Flow: | -486708 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.92 - 125.02) | Sell |
| Bollinger Bands (100): | (94.35 - 116.09) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -12.34 | Sell |
| Relative Strength Index (14 RSI): | 18.92 | Sell |
| Chaikin Money Flow: | -892579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.69 - 99.33) | Sell |
| Bollinger Bands (100): | (89.45 - 127.95) | Sell |
UGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 124.75 | Sell |
| 20-day SMA: | 121.32 | Sell |
| 50-day SMA: | 114.66 | Buy |
| 200-day SMA: | 97.2 | Buy |
| 8-day EMA: | 122.53 | Sell |
| 20-day EMA: | 120.96 | Sell |
| 50-day EMA: | 115.08 | Buy |
| 200-day EMA: | 98.97 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.98 | Sell |
| 20-day SMA: | 75.86 | Sell |
| 50-day SMA: | 96.45 | Sell |
| 200-day SMA: | 122.02 | Sell |
| 8-day EMA: | 61.32 | Sell |
| 20-day EMA: | 73.51 | Sell |
| 50-day EMA: | 90.64 | Sell |
| 200-day EMA: | 112.83 | Sell |
ProShares Ultra Gold Earnings Growth & UGL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.39 per share, a decrease next quarter of $0.51 per share, an increase this year of $5.06 per share, and an increase next year of $5.37 per share.
ProShares Ultra Gold Technical Analysis
| Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||